Description
Olanap 5 mg is a prescription medication manufactured by Incepta Pharmaceuticals Ltd., containing olanzapine, an atypical antipsychotic used to treat various mental health conditions. It is primarily indicated for the acute and maintenance treatment of schizophrenia and related psychoses, addressing both positive symptoms (e.g., delusions, hallucinations, disordered thinking) and negative symptoms (e.g., emotional and social withdrawal, poverty of speech). Additionally, Olanap 5 mg is utilized in the treatment of acute manic or mixed episodes in bipolar disorder, with or without psychotic features and with or without a rapid cycling course.
The typical starting dose for adults is 5 to 10 mg once daily, with adjustments made based on individual clinical response. The maximum recommended dose is 20 mg per day. Olanap 5 mg can be taken with or without food. Common side effects may include drowsiness, dry mouth, constipation, weight gain, and increased blood sugar or cholesterol levels. It's important to note that olanzapine may cause drowsiness, so caution should be exercised when performing tasks that require alertness, such as driving. Additionally, abrupt discontinuation of the medication should be avoided, as it may lead to a worsening of symptoms.
Olanap 5 mg is available in tablet form and should be used under the supervision of a healthcare professional. Regular monitoring is recommended to assess the effectiveness of the treatment and to adjust the dosage as necessary.
.png)
.jpg)
.jpg)
.jpg)
.webp)
.jpeg)
.webp)
.jpg)
.jpeg)
.jpeg)
.jpg)
 100 IU 3 ML.webp)
.jpg)
.jpeg)
 400MG.jpg)
.webp)
.jpg)
.jpg)
Change Language